Allied Signs LOI with Asian Company to Form JV to Expand into the Asian CBD Cosmetic Market
September 20th, 2019
Kelowna, British Columbia–(Newsfile Corp. – September 20, 2019) – Allied Corp. (OTC Pink: ALID) (“Allied”) – an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues – is pleased to announce that it will be expanding its natural health products into the cannabidiol (“CBD”) cosmetic market in Asia with Hong Kong-based CBD Group Asia Limited (“CBD Group Asia”). On September 11, 2019, Allied signed a letter of intent to form a joint venture to leverage CBD Group Asia’s capabilities to distribute Allied’s CBD-based cosmetics and natural health products in China, Hong Kong and throughout Asia.
Under the agreement, Allied and CBD Group Asia will form a joint venture corporation (“JV CO”) that will enable Allied and CBD Group Asia to split the net income from the sales of Allied’s natural health products in the Asian market. Allied will fund the initial launch of JV Co with USD $200,000 which will be reimbursed out of first revenue, after which the revenue will be split 50:50. Allied and CBD Group Asia joint venture is subject to the parties entering into a definitive joint venture agreement.
The launch in early September 2019 of Tactical Relief™ in the United States by an affiliate of Allied caught the attention of CBD Group Asia, which offered Allied an expansion of distribution into Asia. Allied intends to develop a natural health hemp-derived CBD infused cosmetic brand for the Asian market, Asian Life. The first products will be under the product name that is the Mandarin symbol for “living life alive.”
“I am beyond pleased to announce that Allied is in the process of becoming a first mover in the Asian CBD market. We feel that Allied’s natural health products have promising potential in this market, creating additional important revenue potential for Allied,” said Calum Hughes, CEO of Allied Corp.
CBD Group Asia’s principals boast over ten years of experience specializing in the importation and customization of premium Canadian consumer packaged goods (CPGs) for the Chinese marketplace. CBD Group Asia’s management team has previously distributed premium Canadian CPGs into China’s largest retail chains and C-stores, including RT-Mart International Ltd and Carrefour SA. RT-Mart alone operates over 484 retail locations covering 233 cities and 29 provinces in China, generating $20 billion USD in sales in 2018.
By 2024, the CBD market in China alone is forecasted to be worth USD $15 billion, according to Hong Kong-based investment company Regent Pacific Group, citing the beauty and wellness sector as the main driver.
“We are delighted to partner with Allied Corp. to aid their successful entry into Asia alongside us as Joint Venture partners. We feel Allied’s product portfolio fits Asian consumers’ requirements perfectly. We see a huge opportunity to market and brand Allied’s products into one of the largest cosmetics market in the world. We look forward to making this arrangement a huge success alongside Allied and their team,” said James Foster, CEO of CBD Group Asia.
About Allied Corp.
Allied Corp. is an international medical cannabis production company with a mission to address today’s medical issues by researching, creating and producing targeted cannabinoid health solutions. Allied Corp. uses an evidence-informed scientific approach to make this mission possible, through cutting-edge pharmaceutical research and development, innovative plant-based production and unique development of therapeutic products.
About CBD Asia Group
CBD Group Asia (“CGA”) is opening up avenues of growth in embryonic cannabidiol (CBD) markets emerging in Asia. CGA is positioning itself as a conduit in this region through investment in Asian CBD hyper growth stories and distribution of growth orientated North American based CBD brands. CGA is utilising its management team’s decades-long investment, sales and marketing experience of consumer products in Asia in order to grow and expand within the Asian CBD sector.
This news release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Such forward-looking statements include, but are not limited to, that the company will be able to enter into a definitive joint venture agreement with CGA, that the joint venture will be successful and that the joint venture will be successful in selling the proposed natural health hemp-derived CBD infused cosmetic brand Asian Life throughout China, Hong Kong and Asia. We are also subject to various additional risks as described in our SEC filings at www.SEC.gov.
Forward-looking statements are based on management’s current expectations and may materially differ from actual results. Further, such forward-looking statements are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price.
We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.